Publications by authors named "M Nayeri"

α-Glucosidase inhibitors are important in the treatment of type 2 diabetes by regulating blood glucose levels and reducing carbohydrate absorption. The present study focuses on identifying new inhibitors bearing imidazo[1,2-c]quinazoline backbone through multi-step synthesis. The inhibitory potencies of the novel derivatives were tested against Saccharomyces cerevisiae α-glucosidase, revealing IC values ranging from 50.

View Article and Find Full Text PDF
Article Synopsis
  • * The study followed the PRISMA-ScR checklist, extracting data from 197 relevant papers published from 2000 to 2022, and categorized the reasons for euthanasia requests along with contextual factors like legality and human development index.
  • * Findings revealed that the most common conditions leading to euthanasia requests included terminal cancer (45.4%), Alzheimer's and dementia (19.8%), severe physical or mental suffering (19.8%), treatment-resistant mood disorders (12.2%), and advanced cardiovascular diseases (12.
View Article and Find Full Text PDF

It is conventionally expected that the performance of existing gas sensors may degrade in the field compared to laboratory conditions because (i) a sensor may lose its accuracy in the presence of chemical interferences and (ii) variations of ambient conditions over time may induce sensor-response fluctuations (i.e., drift).

View Article and Find Full Text PDF

The role of laparoscopy during a pancreatoduodenectomy (PD) is not clearly defined. The purpose of this study was thus to compare the cost-effectiveness between laparoscopic pancreatoduodenectomy (LPD) and open pancreatoduodenectomy (OPD). From 2010 to 2019, 140 patients underwent PD (60 LPD and 80 OPD).

View Article and Find Full Text PDF

Background: Metastatic signet-ring cell colorectal carcinoma is rare. We analyzed its clinicopathological and molecular features, prognostic factors and chemosensitivity.

Methods: Retrospective study from 2003 to 2017 in 31 French centers, divided into three groups: curative care (G1), chemotherapy alone (G2), and best supportive care (G3).

View Article and Find Full Text PDF